COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema.
作者信息
Fijen Lauré M, Levi Marcel, Cohn Danny M
机构信息
Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands.
Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, The Netherlands.
出版信息
J Allergy Clin Immunol Pract. 2021 Nov;9(11):4156-4158. doi: 10.1016/j.jaip.2021.08.039. Epub 2021 Sep 14.
Abstract
摘要
相似文献
1
COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema.2019冠状病毒病疫苗接种与遗传性血管性水肿患者肿胀风险
J Allergy Clin Immunol Pract. 2021 Nov;9(11):4156-4158. doi: 10.1016/j.jaip.2021.08.039. Epub 2021 Sep 14.
2
Hereditary angioedema and COVID-19 during pregnancy: Two case reports.妊娠期遗传性血管性水肿与新型冠状病毒肺炎：两例病例报告
J Allergy Clin Immunol Pract. 2023 Mar;11(3):961-962. doi: 10.1016/j.jaip.2022.11.045. Epub 2022 Dec 24.
3
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency.新冠病毒病影响伴有或不伴有C1抑制剂缺乏的遗传性血管性水肿患者。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):508-510. doi: 10.1016/j.jaip.2020.11.042. Epub 2020 Nov 30.
4
HAE patient self-sampling for biomarker establishment.HAE 患者生物标志物建立的自我采样。
Orphanet J Rare Dis. 2021 Sep 28;16(1):399. doi: 10.1186/s13023-021-02021-x.
5
Hereditary angioedema with normal C1 inhibitor.遗传性血管性水肿伴正常 C1 抑制剂。
Immunol Allergy Clin North Am. 2013 Nov;33(4):457-70. doi: 10.1016/j.iac.2013.07.002. Epub 2013 Sep 5.
6
Hereditary angioedema with normal C1 inhibitor: an evolving diagnosis.C1抑制剂正常的遗传性血管性水肿：一种不断发展的诊断。
Allergy Asthma Proc. 2012 Nov-Dec;33 Suppl 1:S143-4. doi: 10.2500/aap.2012.33.3634.
7
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks During COVID-19.在新冠疫情期间发作的遗传性血管性水肿患者的精神和临床特征
J Investig Allergol Clin Immunol. 2021 Jul 26;31(4):356-357. doi: 10.18176/jiaci.0701. Epub 2021 May 5.
8
Hereditary angioedema: Repeated attacks in a 10-year-old boy.遗传性血管性水肿：一名10岁男孩反复发病
Pediatr Int. 2019 Jan;61(1):101-103. doi: 10.1111/ped.13729.
9
Mediastinal Angioedema: A Rare Manifestation of Hereditary Angioedema.纵隔血管性水肿：遗传性血管性水肿的一种罕见表现。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):477-478. doi: 10.1016/j.jaip.2020.09.058. Epub 2020 Nov 7.
10
Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.一个土耳其家族中I型遗传性血管性水肿的长期治疗结果
An Bras Dermatol. 2017 Sep-Oct;92(5):655-660. doi: 10.1590/abd1806-4841.20175899.
引用本文的文献
1
Cardiovascular Autonomic Nervous System in a Patient With Hereditary Angioedema Affected by COVID-19.一名感染新型冠状病毒肺炎的遗传性血管性水肿患者的心血管自主神经系统
Cureus. 2024 Mar 19;16(3):e56449. doi: 10.7759/cureus.56449. eCollection 2024 Mar.
2
COVID-19 and vaccination in hereditary angioedema: Single center experience.遗传性血管性水肿中的新冠病毒肺炎及疫苗接种：单中心经验
World Allergy Organ J. 2024 Mar 23;17(4):100892. doi: 10.1016/j.waojou.2024.100892. eCollection 2024 Apr.
3
The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II.分析 COVID-19 大流行对 I 型和 II 型遗传性血管性水肿患者的影响。
Sci Rep. 2023 Nov 22;13(1):20446. doi: 10.1038/s41598-023-47307-1.
4
Sensitivity to change and minimal clinically important difference of the angioedema control test.血管性水肿控制试验对变化的敏感性及最小临床重要差异
Clin Transl Allergy. 2023 Sep;13(9):e12295. doi: 10.1002/clt2.12295.
5
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
6
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know.补体与 COVID-19：三年过去了，我们知道了什么，不知道什么，以及我们应该知道什么。
Immunobiology. 2023 May;228(3):152393. doi: 10.1016/j.imbio.2023.152393. Epub 2023 May 11.
7
[Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].[新冠疫苗接种前进行过敏科会诊的原因及其结果：北莱茵-威斯特法伦州一家过敏中心的两年经验]
Dermatologie (Heidelb). 2023 Jul;74(7):511-519. doi: 10.1007/s00105-023-05152-3. Epub 2023 May 4.
8
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA).C1抑制剂缺乏的血管性水肿患者接种新型冠状病毒肺炎疫苗的安全性和耐受性多中心观察性研究：来自意大利遗传性和获得性血管性水肿网络（ITACA）的数据。
Vaccines (Basel). 2023 Apr 16;11(4):852. doi: 10.3390/vaccines11040852.
9
Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema.抗SARS-CoV-2 mRNA疫苗在一组遗传性血管性水肿患者中的免疫原性和安全性
Vaccines (Basel). 2023 Jan 18;11(2):215. doi: 10.3390/vaccines11020215.
10
Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report.长期预防难治性C1酯酶抑制剂正常的遗传性血管性水肿：一例报告
Cureus. 2023 Jan 15;15(1):e33800. doi: 10.7759/cureus.33800. eCollection 2023 Jan.
Zotero 插件